Russian Covid-19 vaccine will be up for global scrutiny, say experts
Russia's Sechenov University has successfully completed human
trials of its vaccine candidate for the novel coronavirus, according to reports. Experts
say that the global scientific community would now vet the efficacy of the
vaccine before it can be used by countries across the world. Even if all goes
well, it is still sometime away before it can be distributed globally.
Russian
news agency Sputnik said that Vadim Tarasov, the Director of the Institute for
Translational Medicine and Biotechnology, told the agency that the university
has completed the trial of the vaccine developed by the Gamaleya Institute, an
epidemiology research centre in Moscow.
According
to the report, Tarasov said the first group of volunteers would be discharged
on July 15 and the second group on July 20. One group of 18 volunteers received
the vaccine on June 18, while another group of 20 volunteers were given the
vaccine on June 23 at the Practical Research Centre for Interventional
Cardiovasology, Sechenov University. Read More
Comments
Post a Comment